Alzamend Neuro, Inc.·4

Mar 20, 4:30 PM ET

Horne William B. 4

4 · Alzamend Neuro, Inc. · Filed Mar 20, 2025

Insider Transaction Report

Form 4
Period: 2025-03-20
Transactions
  • Purchase

    Common Stock

    2025-03-20$0.98/sh+5,000$4,89226,666 total
Footnotes (1)
  • [F1]The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $0.9783. The range of purchase prices on the transaction date was $0.974 to $0.9799 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.

Documents

1 file
  • 4
    marketforms-68882.xmlPrimary

    PRIMARY DOCUMENT